Home › Free Stock Grades › AXGN
AxoGen, Inc. (AXGN) Stock Grade
AXGN · Healthcare
A+
Market Cap
$1.5B
P/E Ratio
—
Revenue Growth (YoY)
+20.2%
Net Margin
-7.0%
Return on Equity
—
Dividend Yield
None
About AxoGen, Inc.'s fundamentals
AxoGen is a medical device company with a market capitalization of $1.5 billion that is experiencing strong revenue growth of 20.2% year-over-year, indicating expanding sales momentum in its business. However, the company is currently unprofitable, operating at a net margin of -7.0% and reporting a net loss in its latest annual statement, which means it is spending more than it earns. The company does not pay a dividend, which is typical for growth-stage medical device companies still investing heavily to develop and commercialize their products.